- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
CA.3: 6 residues within 4Å:- Chain A: D.293, T.297, A.298, D.324, G.344, G.346
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.293, A:T.297, A:D.324, A:G.344, A:G.346
CA.12: 5 residues within 4Å:- Chain B: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.293, B:T.297, B:D.324, B:G.344, B:G.346, H2O.4
CA.20: 6 residues within 4Å:- Chain C: D.293, T.297, A.298, D.324, G.344, G.346
5 PLIP interactions:5 interactions with chain C- Metal complexes: C:D.293, C:T.297, C:D.324, C:G.344, C:G.346
CA.29: 5 residues within 4Å:- Chain D: D.293, T.297, D.324, G.344, G.346
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.293, D:T.297, D:D.324, D:G.344, D:G.346, H2O.7
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN-MAN.1, NAG-NAG-BMA-MAN-MAN.1
No protein-ligand interaction detected (PLIP)NAG.5: 1 residues within 4Å:- Chain A: N.144
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.144
NAG.13: 1 residues within 4Å:- Chain B: N.144
No protein-ligand interaction detected (PLIP)NAG.21: 2 residues within 4Å:- Ligands: NAG-NAG-BMA-MAN-MAN.18, NAG-NAG-BMA-MAN-MAN.18
No protein-ligand interaction detected (PLIP)NAG.22: 1 residues within 4Å:- Chain C: N.144
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.144
NAG.30: 1 residues within 4Å:- Chain D: N.144
No protein-ligand interaction detected (PLIP)- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
G39.6: 13 residues within 4Å:- Chain A: R.116, E.117, D.149, R.150, W.177, I.221, R.223, A.245, E.275, R.292, N.294, R.374, Y.409
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:W.177, A:I.221, A:A.245
- Hydrogen bonds: A:D.149, A:D.149, A:R.150, A:Y.409
- Water bridges: A:E.117, A:W.177, A:E.276, A:E.276
- Salt bridges: A:R.116, A:R.292, A:R.374
G39.14: 15 residues within 4Å:- Chain B: R.116, E.117, D.149, R.150, W.177, I.221, R.223, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
- Ligands: EDO.17
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:W.177, B:I.221, B:R.223, B:A.245
- Hydrogen bonds: B:E.117, B:R.150, B:E.276, B:E.276, B:Y.409
- Salt bridges: B:R.116, B:R.292, B:R.374
G39.23: 13 residues within 4Å:- Chain C: R.116, E.117, D.149, R.150, W.177, I.221, R.223, A.245, E.275, R.292, N.294, R.374, Y.409
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:W.177, C:I.221, C:A.245
- Hydrogen bonds: C:E.117, C:D.149, C:R.150
- Water bridges: C:E.117, C:W.177, C:E.276
- Salt bridges: C:R.116, C:R.292, C:R.374
G39.31: 15 residues within 4Å:- Chain D: R.116, E.117, D.149, R.150, W.177, I.221, R.223, A.245, E.275, E.276, R.292, N.294, R.374, Y.409
- Ligands: EDO.34
10 PLIP interactions:10 interactions with chain D- Hydrophobic interactions: D:W.177, D:I.221, D:R.223, D:A.245
- Hydrogen bonds: D:E.117, D:R.150, D:E.276
- Salt bridges: D:R.116, D:R.292, D:R.374
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.7: 9 residues within 4Å:- Chain A: R.102, F.103, E.105
- Chain D: A.136, A.137, G.140, G.141, Y.142, Y.143
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: I.262, E.264
Ligand excluded by PLIPEDO.9: 8 residues within 4Å:- Chain A: K.299, R.300, M.317, C.318, T.319, T.321, Y.322, L.323
Ligand excluded by PLIPEDO.10: 7 residues within 4Å:- Chain A: Q.93, K.94, L.455, W.456
- Chain D: D.194, L.201, K.203
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: G.108, N.109
- Chain D: T.106, G.108, N.109
Ligand excluded by PLIPEDO.15: 9 residues within 4Å:- Chain B: D.184, T.189, Y.206, G.234, C.236, I.256, R.257, E.258, G.259
Ligand excluded by PLIPEDO.16: 9 residues within 4Å:- Chain A: E.208
- Chain B: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain B: R.116, R.147, G.148, D.149, W.408, H.439
- Ligands: G39.14
Ligand excluded by PLIPEDO.24: 9 residues within 4Å:- Chain B: A.136, A.137, G.140, G.141, Y.142, Y.143
- Chain C: R.102, F.103, E.105
Ligand excluded by PLIPEDO.25: 2 residues within 4Å:- Chain C: I.262, E.264
Ligand excluded by PLIPEDO.26: 8 residues within 4Å:- Chain C: K.299, R.300, M.317, C.318, T.319, T.321, Y.322, L.323
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain B: D.194, L.201, K.203
- Chain C: Q.93, K.94, L.455, W.456
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain B: T.106, G.108, N.109
- Chain C: G.108, N.109
Ligand excluded by PLIPEDO.32: 9 residues within 4Å:- Chain D: D.184, T.189, Y.206, G.234, C.236, I.256, R.257, E.258, G.259
Ligand excluded by PLIPEDO.33: 9 residues within 4Å:- Chain C: E.208
- Chain D: C.122, G.123, P.124, N.125, E.126, C.127, I.415, K.416
Ligand excluded by PLIPEDO.34: 7 residues within 4Å:- Chain D: R.116, R.147, G.148, D.149, W.408, H.439
- Ligands: G39.31
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.75 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x CA: CALCIUM ION(Non-covalent)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)(Post Translational Modification)
- 4 x G39: (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid(Non-covalent)
- 16 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Escuret, V. et al., A Novel I221 L Substitution in Neuraminidase Confers High Level Resistance to Oseltamivir in Influenza B Viruses. J.Infect.Dis. (2014)
- Release Date
- 2014-05-14
- Peptides
- NEURAMINIDASE: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B